AgingResearch.NewsJoin free

Osteoblastic agents

Osteoblastic agents has been studied in 1 paper since 2021: 1 observational study in people. The newest paper, Aug 1, 2021: “Functional and radiological outcomes of atypical femur fractures among elderly in Karachi, Pakistan”.

Intervention

1 paper studies it1 findingUpdated

See all 1

“Use of post-operative osteoblastic supplements showed statistically significant results with early healing time (p=0.008 [95% CI]).”
Functional and radiological outcomes of atypical femur fractures among elderly in Karachi, PakistanJPMA. The Journal of the Pakistan Medical Association2021

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Humans1

What did studies of Osteoblastic agents find?

1

Studies of Osteoblastic agents measured 1 outcome; the most studied are fracture healing time (1 study).

Fracture healing time

downin humans1

1 study

  1. Osteoblastic agents decrease fracture healing time in humans (p=0.008 [95% CI]).

    “Use of post-operative osteoblastic supplements showed statistically significant results with early healing time (p=0.008 [95% CI]).”

    Humansatypical femur fractures treated with intramedullary nailingn = 24

    Functional and radiological outcomes of atypical femur fractures among elderly in Karachi, Pakistan

    JPMA. The Journal of the Pakistan Medical Association

Latest

Related